Advertisement
Screener

BRIACELL THERAPEUTICS CORP. (BCTX) Total Liabilities and Equity

2.8 / 5 stars · 68/120 Roast Me

BRIACELL THERAPEUTICS CORP. Total Liabilities and Equity

BRIACELL THERAPEUTICS CORP. (BCTX) had Total Liabilities and Equity of $27.07 million as of 2026-04-30, per its 10-Q filed 2026-06-09.

Financial Statements › Balance Sheet

us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-06-09

  • 2026-04-30: Liabilities and Equity $27.07M.
  • 2026-01-31: Liabilities and Equity $33.59M.
  • 2025-10-31: Liabilities and Equity $13.08M.
  • 2025-07-31: Liabilities and Equity $21.65M.
Period endLiabilities and Equity
2026-04-30$27.07M
10-Q · filed 2026-06-09
2026-01-31$33.59M
10-Q · filed 2026-03-10
2025-10-31$13.08M
10-Q · filed 2025-12-11
2025-07-31$21.65M
10-Q · filed 2026-06-09
2025-04-30$17.00M
10-Q · filed 2025-06-16
2025-01-31$9.36M
10-Q · filed 2025-03-12
2024-10-31$10.41M
10-Q · filed 2024-12-16
2024-07-31$5.87M
10-K · filed 2025-10-16
2024-04-30$6.20M
10-Q · filed 2024-06-14
2024-01-31$12.23M
10-Q · filed 2024-03-18
2023-10-31$18.62M
10-Q · filed 2023-12-14
2023-07-31$27.16M
10-K · filed 2024-10-29
2023-04-30$29.72M
10-Q · filed 2023-06-14
2023-01-31$34.16M
10-Q · filed 2023-03-16
2022-10-31$38.45M
10-Q · filed 2022-12-14
2022-07-31$42.58M
10-K · filed 2023-10-25
2021-07-31$58.04M
10-K · filed 2022-10-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
PMGC Holdings Inc. (ELAB)United States$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Celularity Inc (CELU)United States$0.038B-0.34
CervoMed Inc. (CRVO)United States$0.038B-1.39
Edesa Biotech, Inc. (EDSA)Canada$0.039B
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98